Search results for "Cancer"


 
Results 131 - 140 of about 1286 for "Cancer".
Sort by: Relevance | Newest | Oldest

Childhood cancer survivors at higher long-term risk for major surgery

In a study that compared survivors with their siblings, the 35-year mean cumulative count of major surgical interventions at least five years after diagnosis was 206.7 per 100 versus 128.9 per 100, respectively.
https://immattersacp.org/weekly/archives/2023/05/23/4.htm
23 May 2023

The ins and outs of insulin updates, new guidelines, and more

This month's issue addresses insulin, an updated cardiology guideline, and colorectal cancer screening.
https://immattersacp.org/archives/2024/02/the-ins-and-outs-of-insulin-updates-new-guidelines-and-more.htm
1 Feb 2024

More patients undergoing active surveillance for lower-risk prostate cancers

Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023

Taking action to bridge the physician shortage

Addressing the critical physician shortage requires a comprehensive strategy focused on empowering physicians, revamping training models, and reshaping incentives to prioritize patient-centered care.
https://immattersacp.org/archives/2024/04/taking-action-to-bridge-the-physician-shortage.htm
1 Apr 2024

Carcinoids contributed to recent increase in early-onset colorectal cancer rates

While colorectal carcinoid rates are increasing more quickly than colorectal adenocarcinoma rates in younger patients, adenocarcinomas are steadily increasing in almost all early-onset subgroups, including those in their 40s, a U.S. study found.
https://immattersacp.org/weekly/archives/2020/12/15/4.htm
15 Dec 2020

GLP-1 receptor agonists associated with thyroid cancer

Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://immattersacp.org/weekly/archives/2022/11/22/2.htm
22 Nov 2022

Personal risk-based screening for lung cancer may be more cost-effective than recommended cutoffs

While risk-based screening strategies were robustly more cost-effective than the 2021 U.S. Preventive Services Task Force recommendation in a modeling study, whether the results will be replicable in complex real-world clinical practice remains uncertain, an editorial noted.
https://immattersacp.org/weekly/archives/2023/02/07/5.htm
7 Feb 2023

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023

MKSAP Quiz: Evaluation for intestinal metaplasia

A 40-year-old woman is evaluated for intestinal metaplasia found on recent upper endoscopy to assess postprandial pain. No ulcers were visualized but generalized erythema and irregular mucosal pattern was noted. Following biopsy specimens, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2024/01/30/3.htm
30 Jan 2024

Ductal carcinoma in situ linked to higher long-term risks of breast cancer, mortality

Among women who had surgery for ductal carcinoma in situ, rates of developing invasive breast cancer later were lower with more intensive treatment and larger final surgical margins, an English study found.
https://immattersacp.org/weekly/archives/2020/06/02/4.htm
2 Jun 2020

Result Page: Prev   9   10   11   12   13   14   15   16   17   18   Next